Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Equity Ratio (2021 - 2024)

Opus Genetics (IRD) has disclosed Equity Ratio for 8 consecutive years, with 0.93 as the latest value for Q3 2023.

  • On a quarterly basis, Equity Ratio rose 13.81% to 0.93 in Q3 2023 year-over-year; TTM through Sep 2023 was 0.93, a 13.81% increase, with the full-year FY2022 number at 0.94, up 10.75% from a year prior.
  • Equity Ratio was 0.93 for Q3 2023 at Opus Genetics, up from 0.87 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.94 in Q4 2022 to a low of 0.81 in Q1 2021.
  • A 3-year average of 0.87 and a median of 0.87 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: dropped 8.7% in 2022, then grew 13.81% in 2023.
  • Opus Genetics' Equity Ratio stood at 0.85 in 2021, then increased by 10.75% to 0.94 in 2022, then fell by 1.69% to 0.93 in 2023.
  • Per Business Quant, the three most recent readings for IRD's Equity Ratio are 0.93 (Q3 2023), 0.87 (Q2 2023), and 0.91 (Q1 2023).